 Role new antiplatelet agents adjunctive therapies thrombolysis Coronary thrombolysis treatment choice patients acute Q-wave myocardial infarcts contraindications therapy time thrombolysis possibility reocclusion infarct-related artery remain problematic Herein experimental animal studies clinical evaluations attempts adjunctive therapies available thrombolytic interventions time thrombolysis delay prevent reocclusion studies date clear combined thromboxane synthesis inhibitor receptor antagonist serotonin receptor antagonist heparin time thrombolysis delay prevent coronary artery reocclusion experimental canine models copper coil-induced coronary artery thrombi monoclonal antibody platelet glycoprotein IIb/IIIa receptor tissue plasminogen activator t-PA heparin time thrombolysis delays prevents reocclusion experimental canine models Thrombin inhibitors heparin synthetic inhibitors t-PA aspirin time thrombolysis delay prevent coronary artery reocclusion experimental canine models Aspirin intravenous streptokinase reduces mortality patients presumed acute myocardial infarction combination heparin t-PA results infarct-artery patency t-PA heparin Data studies regard possibility effective safe thrombolytic regimens time thrombolysis delay prevent coronary artery reocclusion